Palo Alto, Calif. – July 17, 2013 – Cooley LLP announced today that it represented IDEV Technologies in its $310 million acquisition by Abbott Laboratories. IDEV is a privately-held company focused on developing next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists. Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. The transaction is expected to close by the end of 2013.
The Cooley team was led by partner and chair of the medical device practice, Mark Weeks, and included partners Renee Deming, Mark Windfeld-Hansen, Natasha Leskovsek, Francis Fryscak, Jacqueline Grise, Danish Hamid and Kevin King. Associates Anita Vasudevan, Eric Chow, Michael Baker and Sharon Connaughton also supported the transaction.
View the Abbott press release here.
About Cooley LLP
Cooley's 700 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters. From small companies with big ideas to international enterprises with diverse legal needs, Cooley has the breadth of legal resources to enable companies of all sizes to seize opportunities in today's global marketplace. The firm represents clients across a broad array of dynamic industry sectors, including technology, life sciences, health care, venture capital, clean energy, real estate and retail.
The firm has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC; and Shanghai, China.